Skip to main content

Table 2 Various examples of advanced prototypes of MSNs for bioimaging

From: Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications

Mode

Imaging modalities

Advanced composites

Particle size (nm)

Pore size (nm)

Contrast agent

Animal model

Refs

Single-mode

T1-MRI

MnOx-HMSNs

200

4.4

MnOx

Rats

[459]

MRI

fmSiO4@SPIONs

50

2.8

SPIONs

Mice

[345]

T1 MRI

mSiO2@GGO NPLNPs

50

Cr3+, Nd3+, Gd3Ga5O12

Kunming mice, BALB/c mice

[347]

T1/T2 MRI

MnFe2O4@ mSiO2

50

2.4

MnFe2O4

Kunming mice

[344]

T1/T2 MRI

Fe3O4@MnO/mSiO2

45

2.5

Fe3O4@MnO

[460]

Dual-mode

T1/T2 MRI, FL

Fe3O4@mSiO2

45–105

2–3

FITC, RITC

Balb/c mice

[15]

T2 MRI, FL

Fe3O4-MSN

70 ± 6

2.3

FITC, RITC

Balb/c mice

[461]

PET, CT

89Zr-labelled MSNs

180

8

89Zr

SCID mice

[366]

FL, T1 MRI

MSN@QDs

101.2

3.9

Mn-doped

ZnSe QDs

Balb/c mice

[182]

UCL, CT

UCNPs@mSiO2-POM @FC

120

Yb

Kunming mice

[462]

FL, PAI

17AAG@HMONs-

Gem-PEG

60

ICG

Balb/c mice

[463]

TPF,

T2 MRI

Fe3O4@CDs@mSiO2

@PTX@mSiO2

91

2.9

Fe3O4, CDs

Balb/c mice

[464]

T2 MRI, PL

CoFe2O4@mSiO2

52

8

-

[465]

T1 MRI, FL

MS‐Gd2O3:Eu@PEG

190 in length, 70 in width

 ~ 4

Gd2O3

[211]

T2 MRI, FL

Fe3O4@mSiO2

-CD-FA

100–150

4.72

CD, Fe3O4

[466]

T1 MRI, PL

GdVO4:Eu3+@mSiO2

75

3.3

GdVO4, Eu3+

[361]

19F MRI, FL

Au-FMSNs

 ~ 100

 < 1.2

Au, C6F6, FITC

[467]

T2 MRI, FL

MSN-Gd

 > 75

1.4–2.9

Gd3+

[468]

UCL, PAI

UCNP@mSiO2-ICG

 ~ 60

Nd, Er, ICG

ND4 Swiss Webster mice

[270]

T2 MRI, CT

M-MSN(Dox/Ce6)/

PEM/P-gp shRNA

280 ± 17

2.482

Fe3O4-Au

Balb/c mice

[264]

T1 MRI, UCL

NaYF4: Yb/Er@NaGdF4@

SiO2@mSiO2

240–265

2.23, 4.01

Gd

Balb/c mice

[469]

T1 MRI, FL

Gd-Al@MSNs

57

2.5

Gd-Al, Cy5

Balb/c mice, Kunming mice

[470]

UCL, CT

Y2O3:Yb, Er@mSiO2

340

4.6

Y2O3:Yb,

Er

Balb/c mice

[471]

FL, CT

A-AuNC@PAA/mSiO2

120

2

Au

Balb/c mice

[472]

MRI, UCL

β‐NaYF4:Yb3+, Er3+ @β‐NaGdF4:Yb3+@mSiO2

78

2.9

β‐NaYF4:

Yb3+, Er3+ @β‐NaGdF4:

Yb3+

Kunming mice

[473]

T1 MRI, UCL

MUCNCs@SNTs

95 in wall thickness

5

NaYF4:Yb/

Er/Gd

[474]

T2 MRI, FL

Hydrazine-MSN-

FITC-Fe3O4-PEG

Fe3O4, FITC

[353]

Multi-mode

FL, MRI, CT

WS2-IO@MS-PEG

2.48

WS2, Iron oxide

Balb/c mice

[141]

PAI, PET, FL

CuSNDs@DOX-MSNs

100

6

CuSNDs

Nude mice

[475]

US, CT, PAI, Thermal

HMSs@Au-PFH-mPEG NSs

200

3.8

Au

Balb/c mice

[374]

T2 MRI, FL Thermal

Au-NRs-MMSNEs

300 × 180

2–3.5

Au, Fe3O4

SD mice

[142]

PT, FL, T1 MRI

RGD-CCmMC

116.5

2.9 ± 0.3

Mn-Cdots, gold cube-in-cube

Balb/c mice

[476]

T2 MRI, US, FL

mSiO2-MNPs

9.4 ± 1.2

2, 4

Fe3O4, FITC

[370]

TPL, TPEF, FL, PAI, PT

GNR@mSiO2-5-FU

54.14 ± 4.39 in length and 15.87 ± 1.28 in width, a shell of 19.85 ± 1.67

 

GNRs, ICG

Balb/c mice

[477]

SR‐STXM, CT, T1 MRI, PA

Au@SiO2(Gd)@HA

232.7

Gd

Balb/c mice

[346]

T2 MRI, PAI, BL

GRMNBs

130

2.1

Au, Fe3O4

C57BL/6 mice

[371]

PAI, MRI, FL

Au@SiO2

200

4.6

AuQDs

CD1 mice

[478]

UCL, CT, PT,

T1/T2 MRI

GdOF: Ln@SiO2

ZnPc-CDs-FA

293

3.53

GdOF, ZnPc, CDs

Balb/c mice

[479]

T1 MR, CT, UCL

UCMSNs

-

3.1

Yb3+, Gd3+

Balb/c mice

[273]

T1 MRI, PET, FL

MSN@Gd@64Cu

 ~ 60

-

Gd3+, 64Cu, FITC

Balb/c mice

[358]

T1 MRI, FL, US

MSN-Gd

384 ± 134 nm

4.1 ± 1.1 nm

GdCl3, Fluorescein

nude mice

[480]

US, CEUS,

T2 MRI

Fe-HSNs

200.3 ± 15.2

6.03

-

C57BL mice, ApoE-/- mice

[368]

T2 MRI, CT, FL

i-fmSiO4@SPIONs

50

2.7

Fe3O4

[373]

  1. 17-AAG: 17-N-allylamino-17-demethoxygeldanamycin or Tanespimycin; 5-FU: 5-Fluorouracil; A-AuNC: Aggregated gold nanocluster; Al: Aluminum; Au: Gold; BL: Bioluminescent; CDs: Carbon dots; CEUS: Contrast-enhanced ultrasound; Ce6: Chlorin e6; CPT: Camptothecin; CT: Computed tomography; Cu: Copper; Cy 5: Cyanine 5; DOX: Doxorubicin; FA: Folic acid; FITC: Fluorescein isothiocynate; FC: Folate-chitosan; FL: Fluorescence; FMSNs: Fluorescein-functionalized MSNs; Gd: Gadolinium; Gem: Gemcitabine; GNR@mSiO2: Mesoporous silica‐coated gold nanorods; GRMNBs: Multi‐gold nanorods crystal‐seeded magnetic mesoporous silica nanobeads; HA: Hyaluronic acid; HMONs: Hollow mesoporous organosilica nanocapsule; HMS -Hollow mesoporous silica; HSN: Hollow silica nanoparticles; i-fmSiO4@SPIONs: Iodinated oil-loaded mesoporous silica-coated superparamagnetic iron oxide nanoparticles; ICG: Indocyanine green; mC: Magnetic carbon; MMSNEs- Magnetic mesoporous silica nanoellipsoids; Mn: Manganese; MNPs: Mesoporous silica-coated magnetic nanoparticles; mPEG: Methoxypoly(ethylene glycol); MRI: Magnetic resonance imaging; mSiO2 or MS: Mesoporous silica; MSNs: mesoporous silica nanoparticles; MUCNCs@SNTs: Silica nanotubes functionalized with NaYF4:Yb/Er/Gd nanocrystals; NPLNPs: Near-infrared persistent luminescence nanoparticles; NRs: Nanorods; NSs: Nanostars; P-gp: P-glycoprotein; PAA: Polyacrylic acid; PAI: Photo acoustic imaging; PEG: Poly(ethylene glycol); PEM: Alginate/chitosan-based polyelectrolyte multilayers; PET: Positron emission tomography; PFH: Perfluorohexane; PL: Photoluminescence; POM: Polyoxometalate; PT: Photothermal; PTX: Paclitaxel; QDs: Quantum dots; RITC: Rhodamine isothiocyanate; ShRNA: small hairpin ribose nucleic acid; SR-STXM: Synchrotron radiation scanning transmission X‐ray microscopy; TA: Trimethylammonium groups; TPEF: Two‐photon excitation fluorescence; TPF: Two‐photon fluorescence; TPL: Two‐photon luminescence; TRF: Transferrin; UCNPs: Upconversion nanoparticles; UCL: Upconverting luminescence; UMSCs: Umbilical cord‐derived mesenchymal stem cells; UCMSNs: NaGdF4:Yb,Er@NaGdF4:Yb@NaNdF4@mSiO2-CuS-PEG; US: Ultrasound; Yb3+: ytterbium trivalent ion